Gilead Announces Phase 3 Results for Investigational Once-Daily Single Tablet HIV Regimen Containing Tenofovir Alafenamide (TAF)

Uncategorized February 27, 2015 at 12:13 PM 0 comments

– First TAF-Based Regimen Found to Be Non-Inferior with Improved Renal and Bone Parameters Compared to Stribild® –   Seattle, February 26, 2015 – Gilead Sciences, Inc. (NASDAQ: GILD) today announced detailed 48week results from two Phase 3 studies (Studies 104 and 111) evaluating its investigational once-daily single tablet regimenRead More

Living with a Rare Cancer

Oncology February 25, 2015 at 1:58 PM 0 comments

Rare Disease Day 2015 seeks to raise awareness of the challenges faced by patients and their families. Lugano, 25 February 2015 – Within the “umbrella” of rare diseases, rare cancer patients confront particular problems. Most rare diseases have an identified genetic origin.  In contrast, rare cancers are mainly acquired diseases.Read More

Virtual Blood Could Be the Key to More Effective Treatments for Blood Cancers

Virtual Blood Could Be the Key to More Effective Treatments for Blood Cancers

Hematology February 23, 2015 at 9:21 AM 0 comments

DEVELOPMENT of treatments for leukaemia and lymphoma could be aided by a new computer model that simulates the development of blood cells, according to researchers at the University of Cambridge and Microsoft Research, Cambridge, UK. Around 30,000 new patients are diagnosed with cancers of the blood every year in theRead More

Combination Therapy Trial for Breast Cancer

Combination Therapy Trial for Breast Cancer

Oncology February 23, 2015 at 9:15 AM 0 comments

BREAST cancer patients with small node-negative HER2-positive tumours achieved 3-year survival approaching 100% with adjuvant paclitaxel and trastuzumab, in a recent multicentre prospective trial. This could turn the standard of care (SoC) for HER2-positive patients away from conventional chemotherapy. ­ Patients included in the trial had a 3-year invasive disease-freeRead More

Anti-Cancer Transformers: The next Generation Self-Assembling Arsenal

Anti-Cancer Transformers: The next Generation Self-Assembling Arsenal

Oncology February 23, 2015 at 9:03 AM 0 comments

PROGRAMMABLE biomaterial that is capable of spontaneously assembling into a fighting structure once injected into a living body has the potential to fight and prevent cancer along with a number of other serious diseases. Researchers are investigating the use of biodegradable rods known as mesoporous silica rods (MSRs) which canRead More

InflectraTM (Infliximab) Patient Registry Reports Interim Results in the Treatment of Inflammatory Bowel Disease

Uncategorized February 19, 2015 at 2:11 PM 0 comments

- Hungarian National Registry reports interim results following Inflectra therapy in 90 patients with Crohn’s disease and ulcerative colitis – These data add to the growing body of evidence supporting the efficacy and safety of Inflectra treatment in inflammatory bowel disease BARCELONA and MADRID, Spain, Feb. 19, 2015 — DataRead More

Hospira Launches First Biosimilar Monoclonal Antibody (mAb) InflectraTM (Infliximab) in Major European Markets

Uncategorized February 16, 2015 at 11:43 AM 0 comments

Major European markets can finally benefit from the availability of Inflectra following the patent expiry of reference product Remicade® (infliximab) Inflectra provides an alternative, potentially more affordable treatment option for people suffering from severe, debilitating diseases such as rheumatoid arthritis and inflammatory bowel disease while maintaining comparable quality, efficacy andRead More

Can the Menstrual Cycle Influence Cigarette Craving?

Can the Menstrual Cycle Influence Cigarette Craving?

Reproductive Health February 16, 2015 at 9:38 AM 0 comments

WOMEN looking to give up smoking may need to consider the potential impact of their menstrual cycle on their ability to resist nicotine craving. Differences in the brain activity of nicotine craving between men and women, and the variation of this activity across the menstrual cycle in women, were theRead More

Innovative Procedure to Make Placenta Accreta-Complicated Births Safer

Innovative Procedure to Make Placenta Accreta-Complicated Births Safer

Reproductive Health February 16, 2015 at 9:37 AM 0 comments

TREATMENT involving the use of balloons could potentially save the lives of women who have a pregnancy complication called placenta accreta (PA) – the abnormal implantation of the placenta in the uterus. The results, based upon a study of 21 patients over a period of 44 months who received theRead More

Human Primordial Germ Cells to Pave the Way in Fertility Treatments

Human Primordial Germ Cells to Pave the Way in Fertility Treatments

Reproductive Health February 16, 2015 at 9:34 AM 0 comments

ADVANCES in treatments for fertility problems and age-related diseases are set to take place following a new breakthrough by researchers. A team of scientists from the UK and Israel have successfully used human embryonic stem cells (SCs) and adult human skin cells to make primordial germ cells (PGCs) – precursorsRead More